Dr. David James Smits , MD
Ophthalmology โข Boston, MA
243 Charles St
Boston, MA 02114
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 31, 2014; this date does not establish years in practice.
-
Published CMS data list 7,880 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 โ Injection, faricimab-svoa, 0.1 mg: 3,660 service units.
- 92014 โ Established patient complete exam of visual system: 799 service units.
- 92134 โ Imaging of retina: 577 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,116 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost โ 255 prescription fills, including refills.
- Prednisolone Acetate โ 143 prescription fills, including refills.
- Brimonidine Tartrate โ 104 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Boston, MA (2024, 180 clinicians with data). Median for this group: 1,057. Middle half: 277 to 2,414.
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,042 in 2020 to 7,880 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
243 Charles St
Boston, MA 02114
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Cheyenne Eye Clinic Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Colorado School Of Medicine, Denver
2014
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,270 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $857,539 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $640,866 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,858 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$137,161 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $590.83 across 26 records.
By nature of payment
- Food and Beverage: $590.83 across 26 records.
Reporting-company totals (3 largest of 10)
- ABBVIE INC.: $222.94 across 12 records.
- Bausch & Lomb Americas Inc.: $95.94 across 2 records.
- Tarsus Pharmaceuticals, Inc.: $94.95 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
12 years (graduated 2014)
CMS Doctors and Clinicians data list 2014 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2014
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Smits has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Smits as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Boston, MA (2024, 180 clinicians with data). Median for this group: 1,057. Middle half: 277 to 2,414.
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Boston, MA (2024, 180 clinicians with data). Median for this group: $110,271. Middle half: $25,163 to $220,753.
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $194,367. Middle half: $57,908 to $416,629.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Boston, MA (2024, 180 clinicians with data). Median for this group: $81,255. Middle half: $18,640 to $162,894.
A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $144,463. Middle half: $40,965 to $304,911.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Ophthalmology in Boston, MA (2024, 200 clinicians with data). Median for this group: 434. Middle half: 120 to 1,252.
Close to the middle for clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: 764. Middle half: 219 to 2,063.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Ophthalmology in Boston, MA (2024, 200 clinicians with data). Median for this group: $26,962. Middle half: $3,441 to $138,014.
A higher Part D drug cost than 65% of clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: $61,248. Middle half: $7,840 to $214,090.
327 active clinicians are listed under Ophthalmology with a practice address in Boston, MA (792 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
5.2% of these 327 clinicians have the CMS telehealth indicator.
56.6% of these 327 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 30% from 6,042 in 2020 to 7,880 in 2024.
- 2020: 6,042
- 2021: 6,823
- 2022: 7,481
- 2023: 4,696
- 2024: 7,880
-
Medicare-allowed amount
Medicare-allowed amount decreased 40% from $1,419,068 in 2020 to $857,539 in 2024.
- 2020: $1,419,068
- 2021: $1,558,474
- 2022: $1,214,476
- 2023: $884,616
- 2024: $857,539
-
Paid by Medicare
Paid by Medicare decreased 41% from $1,091,655 in 2020 to $640,866 in 2024.
- 2020: $1,091,655
- 2021: $1,198,017
- 2022: $920,327
- 2023: $660,806
- 2024: $640,866
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 51% from 739 in 2020 to 1,116 in 2024.
- 2020: 739
- 2021: 587
- 2022: 667
- 2023: 885
- 2024: 1,116
-
30-day fills
30-day fills increased 100% from 930 in 2020 to 1,858 in 2024.
- 2020: 930
- 2021: 766
- 2022: 943
- 2023: 1,291
- 2024: 1,858
-
Part D drug cost
Part D drug cost increased 142% from $56,617 in 2020 to $137,161 in 2024.
- 2020: $56,617
- 2021: $55,992
- 2022: $47,565
- 2023: $102,075
- 2024: $137,161
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $54.26 in 2021 to $590.83 in 2025.
- 2021: $54.26
- 2022: $433.52
- 2023: $566.20
- 2024: $390.85
- 2025: $590.83
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 26 records totaling $590.83.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
MIEBO | General | $69.03 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Clareon PanOptix Pro | General | $33.55 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $29.99 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Rocklatan | General | $27.62 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $27.07 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
MIEBO | General | $26.91 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $26.74 |
| Oyster Point Pharma, Inc. |
Food and Beverage
In-kind items and services
|
TYRVAYA | General | $24.10 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $23.41 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $22.69 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $22.33 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $21.78 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $21.08 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $20.79 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $20.79 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $20.63 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $20.03 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $18.96 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $18.67 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $18.16 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $16.65 |
| BIOTISSUE HOLDINGS INC. |
Food and Beverage
In-kind items and services
|
โ | General | $16.45 |
| Glaukos Corporation |
Food and Beverage
Cash or cash equivalent
|
iDoseTR | General | $16.44 |
| LENSAR, Inc. |
Food and Beverage
Cash or cash equivalent
|
LENSAR LASER SYSTEM | General | $12.20 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $10.21 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2017โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2018โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
3,660 | 11 | $45.00 | $34.50 |
|
92014
Established patient complete exam of visual system
|
799 | 699 | $192.00 | $122.71 |
|
92134
Imaging of retina
|
577 | 316 | $161.00 | $39.28 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
544 | 358 | $195.00 | $124.24 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
376 | 218 | $2800.00 | $494.47 |
|
92136
Measurement of corneal curvature and depth of eye
|
330 | 229 | $150.00 | $38.61 |
|
92133
Imaging of optic nerve
|
303 | 239 | $161.00 | $34.07 |
|
67028
Injection of drug into eye
|
248 | 41 | $296.37 | $119.00 |
|
J0178
Injection, aflibercept, 1 mg
|
244 | 21 | $1526.39 | $828.81 |
|
92083
Exam of visual field with extended testing
|
205 | 181 | $155.00 | $62.03 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
144 | 127 | $133.00 | $88.11 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
106 | 106 | $253.00 | $162.49 |
|
J9035
Injection, bevacizumab, 10 mg
|
75 | 13 | $150.00 | $72.28 |
|
92004
New patient complete exam of visual system
|
69 | 69 | $228.00 | $145.89 |
|
92020
Exam of the internal drainage system of eye
|
67 | 66 | $93.00 | $26.72 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
48 | 47 | $1533.13 | $362.00 |
|
76514
Ultrasound scan of cornea to determine thickness
|
43 | 42 | $33.00 | $10.25 |
|
66982
Complex removal of cataract with insertion of prosthetic lens
|
31 | 25 | $3300.00 | $705.53 |
|
65855
Laser repair to improve eye fluid flow
|
11 | 11 | $3166.64 | $241.07 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 255 | 15,511 | $3,150.61 | 85 |
| Prednisolone Acetate | Prednisolone Acetate | 143 | 3,464 | $4,829.65 | 102 |
| Brimonidine Tartrate | Brimonidine Tartrate | 104 | 3,912 | $1,733.52 | 31 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 98 | 5,519 | $1,519.95 | 35 |
| Lumigan | Bimatoprost | 76 | 4,946 | $44,661.40 | 22 |
| Dorzolamide Hcl | Dorzolamide Hcl | 63 | 3,546 | $1,225.53 | 19 |
| Timolol Maleate | Timolol Maleate | 47 | 3,048 | $582.75 | 27 |
| Fluorometholone | Fluorometholone | 44 | 1,597 | $2,858.69 | 33 |
| Moxifloxacin | Moxifloxacin Hcl | 36 | 582 | $1,129.94 | 25 |
| Rhopressa | Netarsudil Mesylate | 36 | 1,278 | $16,247.86 | โ |
| Erythromycin | Erythromycin Base | 35 | 372 | $370.64 | 23 |
| Alphagan P | Brimonidine Tartrate | 30 | 1,224 | $14,481.68 | โ |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 24 | 393 | $301.80 | 21 |
| Travoprost | Travoprost | 20 | 826 | $3,457.34 | โ |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 19 | 504 | $496.58 | 16 |
| Restasis | Cyclosporine | 18 | 1,260 | $22,192.98 | โ |
| Simbrinza | Brinzolamide/Brimonidine Tart | 16 | 563 | $2,984.38 | โ |
| Combigan | Brimonidine Tartrate/Timolol | 14 | 476 | $4,157.56 | โ |
| Bimatoprost | Bimatoprost | 14 | 816 | $1,451.02 | โ |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 12 | 710 | $7,480.18 | โ |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | 333 | $1,846.48 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0009X
An ophthalmologist who specializes in the treatment of glaucoma and other disorders related to increased intraocular pressure and optic nerve damage. This specialty involves the medical and surgical treatment of these conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20190718001537
WY
7012212467
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Cheyenne Eye Clinic Llc
1300 E 20th St, Cheyenne, WY 820014021
Phone: 3076342020
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 925 N LINCOLN ST, APT 7A, DENVER, CO 802032767 (Tel: 7205601940)
Registered at 243 CHARLES ST, BOSTON, MA 02114 (Tel: 6175733689)
Registered at 243 CHARLES ST, BOSTON, MA 021143002 (Tel: 6175733689)
Recorded as DAVID SMITS, MD
Ophthalmology (license number reported to NPPES: MA 274392)
NPI status registered as active in NPPES database
Registered at 1721 E 19TH AVE, DENVER, CO 802181251 (Tel: 7205601940)
Registered at 7347 S SEDALIA ST, FOXFIELD, CO 800161644 (Tel: 7205601940)
Recorded as DAVID SMITS
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Boston
- Dr. Aaron Kaufman, MD
- Dr. Michael Raizman, MD
- Dr. Carolyn Wu, MD
- Dr. Eric Pierce, MD, PhD
- Dr. Bradley Hansen, MD
- Dr. Ying Jiang, MD
Mailing Address
925 N Lincoln St, Apt 7a
Denver, CO 802032767
Phone: 7205601940